Looking to publish in Bone Marrow Transplantation? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowBone Marrow Transplantation publishes peer reviewed original research and reviews addressing all aspects of basic biology and clinical use of haemopoietic cell transplantation. It is the official journal of the EBMT.
Looking to publish in Bone Marrow Transplantation? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Bone Marrow Transplantation accepts the following article types. Click on an article type to view submission instructions.
Article
Review Article
Correspondence
Technical Report
Perspective
Recent Publications
Prognostic factors and a novel scoring system for allogeneic hematopoietic stem cell transplantation in patients aged 70 years or older: a nationwide registry analysis in Japan
Asami Kataoka, Noriyoshi Yoshinaga, Yoshitaka Inoue, Tomomi Toubai, Naoyuki Uchida, Kazuto Ogura, Yasufumi Uehara, Naoyuki Anzai, Toshio Wakayama, Atsushi Wake, Noriko Doki, Masahito Tokunaga, Tetsuya Eto, Norimichi Hattori, Masatsugu Tanaka, Mitsumasa Watanabe, Tomohiko Kamimura, Koji Kawamura, Takahiro Fukuda, Marie Ohbiki, Yoshiko Atsuta, Hideki Nakasone, Kimikazu Yakushijin, Junya Kanda
Risk factors for EBV reactivation and impact of graft composition following GVHD prophylaxis with rabbit ATG or PTCy
Stéphanie Thiant, Simon Dufresne, Imran Ahmad, Sandra Cohen, Jean-Sébastien Delisle, Omar Eduardo Fernandez-Vargas, Thomas Kiss, Silvy Lachance, Denis Claude Roy, Olivier Veilleux, Léa Bernard, Daiana Gisela Rodriguez, Guy Sauvageau, Jean Roy
Impact of fludarabine dosage on outcomes in large B-cell lymphoma patients treated with CAR T-cell therapy: a retrospective study of the CTIWP of the EBMT
Guillaume Dachy, Jarl E. Mooyaart, Ludovic Gabellier, Ibrahim Yakoub-Agha, Michael Daskalakis, Victoria Potter, Peter Dreger, Anne Huynh, Christof Scheid, Matthew Collin, Gabriel Brisou, Gerald Wulf, Rachel Protheroe, Carlos Solano Vercet, Lucía López-Corral, Peter Vandenberghe, Francis Ayuk, Stefania Bramanti, Marjolein van der Poel, Jorinde D. Hoogenboom, Jürgen Kuball, Annalisa Ruggeri, Florent Malard
Non-gene-edited, CD19-targeted, allogeneic CAR-T cell therapy for relapsed or refractory B-cell acute lymphoblastic leukemia: an open-label, single-arm phase 1 study
Chenxue Wu, Lei Xue, Miaomiao Wu, Sujun Li, Qianwen Xu, Kaichun Liu, Hui Li, Hui Xu, Liyun Yang, Tao Wang, Rong Jin, Xingbing Wang
Clonal Hematopoiesis does not influence manufacturing of Chimeric Antigen Receptor (CAR) T-Cells
Simon M. Krauß, Konstantin Weibl, Enrica Bach, Mandy Brückner, Anne Weigert, Theresa Tumewu, Elena Ruschpler, Gunhild Vogtmann, Sandra Hoffmann, Olaf Penack, Martin Janz, Raymund Buhmann, Reinhard Henschler, Lars Bullinger, Ulrich Keller, Sebastian Schwind, Maximilian Merz, Madlen Jentzsch, Georg-Nikolaus Franke, Marco Herling, Uwe Platzbecker, Klaus H. Metzeler, Vladan Vučinić
Frequently asked questions
How long does it take to publish?
Submission to first editorial decision (median days): 3. Submission to acceptance (median days): 93.
Reformat to Bone Marrow Transplantation using Livewrite PremiumIs a cover letter required?
A cover letter is required. It should include the affiliation and contact information for the corresponding author, explain the importance of the work and its suitability for the journal readership, confirm originality and exclusive submission, and include previous reviewer comments if the manuscript was previously considered by another journal.
Reformat to Bone Marrow Transplantation using Livewrite PremiumWhat are the publication costs?
Funder-compliant open access options.
Reformat to Bone Marrow Transplantation using Livewrite Premium